3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Glioblastoma
7
Urinary Bladder Neoplasms
6
Breast Neoplasms
6
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Carcinoma
5
Burkitt Lymphoma
5
Astrocytoma
5
Sarcoma
4
Squamous Cell Carcinoma of Head and Neck
3
Rhabdomyosarcoma, Embryonal
3
Pancreatic Neoplasms
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Adenocarcinoma of Lung
3
Triple Negative Breast Neoplasms
2
Sarcoma, Synovial
2
Sarcoma, Ewing
2
Rhabdomyosarcoma, Alveolar
2
Rhabdomyosarcoma
2
Rectal Neoplasms
2
Prostate Adenocarcinoma
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Melanoma
2
Interventions
durvalumab
2
Tretinoin
2
Paclitaxel
2
Carboplatin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Pemetrexed
1
MK 2206
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Radiation
×
30 days
×
Clear all
No trials found.